Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 21207373)

1.

IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, Dahiya R.

Int J Cancer. 2011 Nov 15;129(10):2360-9. doi: 10.1002/ijc.25899. Epub 2011 Apr 7.

PMID:
21207373
2.

A possible role for the WNT-1 pathway in oral carcinogenesis.

Lo Muzio L.

Crit Rev Oral Biol Med. 2001;12(2):152-65. Review.

3.

The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.

Li C, Shi X, Zhou G, Liu X, Wu S, Zhao J.

Front Biosci (Landmark Ed). 2013 Jun 1;18:1384-91. Review.

PMID:
23747891
4.

A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.

García-Jiménez C, García-Martínez JM, Chocarro-Calvo A, De la Vieja A.

J Mol Endocrinol. 2013 Dec 19;52(1):R51-66. doi: 10.1530/JME-13-0152. Print 2014 Feb. Review.

5.

The complex roles of Wnt antagonists in RCC.

Saini S, Majid S, Dahiya R.

Nat Rev Urol. 2011 Oct 25;8(12):690-9. doi: 10.1038/nrurol.2011.146. Review.

PMID:
22025172
6.

Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop.

Perotti D, Hohenstein P, Bongarzone I, Maschietto M, Weeks M, Radice P, Pritchard-Jones K.

Mol Cancer Ther. 2013 Dec;12(12):2619-27. doi: 10.1158/1535-7163.MCT-13-0335. Epub 2013 Nov 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk